This study aims to test the safety and effectiveness of batoclimab in treating patients with Myasthenia Gravis.
Age & Gender
- 18 years ~ 99 years
- Male, Female, Gender Inclusive
Study Interest
- Brain, Head, Nervous System
Visit Location
Burnett-Womack Building (UNC-Chapel Hill)
Status: Open